RRM Outcomes: Published Evidence documents the live birth rates achieved by Restorative Reproductive Medicine and NaProTECHNOLOGY in peer-reviewed literature. Several key studies characterize outcomes across diverse infertility populations.
Boyle et al. (2025, Journal of Restorative Reproductive Medicine, n=187, NeoFertility Dublin) reported a crude live birth rate of 41% and an adjusted cumulative live birth rate of 50% at 24 months, with a preterm birth rate in singletons of 4.0%. Sanchez-Mendez et al. (2025, Frontiers in Reproductive Health, n=1,310) reported a crude live birth rate of 35.3% and adjusted cumulative rates of 50.0% at 24 months and 62.1% at 36 or more months. Stanford et al. (2022, Human Reproduction Open) reported a 29% cumulative live birth rate at 24 months in a primary infertility population. Tham et al. (2012, Canadian Family Physician, n=108) reported an adjusted cumulative live birth rate of 66% at 24 months.
These rates compare favorably to IVF, which the HFEA reports at approximately 33% per embryo transferred, while RRM studies document significantly lower preterm birth and multiple birth rates. The evidence base reflects outcomes achieved by identifying and treating root causes in both partners rather than bypassing reproductive physiology.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.